CL2015000076A1 - Inmunohistoquimica anti-mif - Google Patents

Inmunohistoquimica anti-mif

Info

Publication number
CL2015000076A1
CL2015000076A1 CL2015000076A CL2015000076A CL2015000076A1 CL 2015000076 A1 CL2015000076 A1 CL 2015000076A1 CL 2015000076 A CL2015000076 A CL 2015000076A CL 2015000076 A CL2015000076 A CL 2015000076A CL 2015000076 A1 CL2015000076 A1 CL 2015000076A1
Authority
CL
Chile
Prior art keywords
mif
immunohistochemistry
mif immunohistochemistry
Prior art date
Application number
CL2015000076A
Other languages
English (en)
Inventor
Michael Thiele
Randolf Kerschbaumer
Dirk Voelkel
Patrice Douillard
Friedrich Scheiflinger
Alexander Schinagl
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of CL2015000076A1 publication Critical patent/CL2015000076A1/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CL2015000076A 2012-07-10 2015-01-09 Inmunohistoquimica anti-mif CL2015000076A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261669964P 2012-07-10 2012-07-10
US201261719793P 2012-10-29 2012-10-29
US201361778117P 2013-03-12 2013-03-12

Publications (1)

Publication Number Publication Date
CL2015000076A1 true CL2015000076A1 (es) 2015-04-24

Family

ID=48748254

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015000076A CL2015000076A1 (es) 2012-07-10 2015-01-09 Inmunohistoquimica anti-mif

Country Status (14)

Country Link
US (1) US11402388B2 (es)
EP (1) EP2872897B1 (es)
JP (1) JP2015523572A (es)
KR (1) KR20150029017A (es)
CN (1) CN105452867A (es)
CA (1) CA2878494A1 (es)
CL (1) CL2015000076A1 (es)
CO (1) CO7240371A2 (es)
HK (1) HK1209839A1 (es)
IL (1) IL236584A0 (es)
NZ (1) NZ628459A (es)
RU (1) RU2015104160A (es)
WO (1) WO2014009355A1 (es)
ZA (1) ZA201500138B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106068456A (zh) * 2014-01-03 2016-11-02 百深有限责任公司 抗‑mif免疫组织化学
CN111929437A (zh) * 2020-07-10 2020-11-13 吉林金域医学检验所有限公司 一种呼吸道病原体抗原检测的样本处理方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068178A (en) * 1988-12-06 1991-11-26 Genetic Systems Corporation Method of enhancing direct immunofluorescence staining of cells
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies
US5116734A (en) * 1989-09-01 1992-05-26 Digene Diagnostics, Inc. Highly sensitive method for detecting peroxidase
US6645493B1 (en) * 1993-05-17 2003-11-11 The Picower Institute For Medical Research Composition containing anti-MIF antibody
WO2001064749A2 (en) * 2000-02-28 2001-09-07 Idec Pharmaceuticals Corporation Method for preparing anti-mif antibodies
WO2002076503A1 (en) * 2000-06-20 2002-10-03 Mayo Foundation For Medical Education And Research Treatment of central nervous system diseases by antibodies against glatiramer acetate
US20040029825A1 (en) * 2001-10-03 2004-02-12 Davies Christopher J Methods of minimizing immunological rejection of a nuclear transfer fetus
CA2426571A1 (en) * 2000-11-01 2002-05-10 Eleftherios P. Diamandis Detection of ovarian cancer
WO2004101756A2 (en) 2003-05-09 2004-11-25 Diadexus, Inc. Ovr110 antibody compositions and methods of use
GB0315991D0 (en) 2003-07-08 2003-08-13 Dakocytomation Denmark As Standard
CA2575791A1 (en) * 2004-08-03 2006-02-16 Dyax Corp. Hk1-binding proteins
US20090220521A1 (en) * 2008-01-04 2009-09-03 Randolf Kerschbaumer Anti MIF Antibodies
CN102939538A (zh) * 2010-05-07 2013-02-20 霍夫曼-拉罗奇有限公司 用于离体检测细胞的诊断方法
WO2013050457A1 (en) * 2011-10-07 2013-04-11 Baxter Healthcare S.A. Characterization of cho-mif gene and protein, and use thereof
US9958456B2 (en) * 2011-10-07 2018-05-01 Baxalta Incorporated OxMIF as a diagnostic marker
AU2013202693B2 (en) 2012-04-16 2015-01-22 Baxalta GmbH Combination Therapy of Anti-MIF Antibodies and Chemotherapeutics
AU2013203957B9 (en) 2012-04-16 2015-10-15 Baxalta GmbH Combination Therapy of Anti-MIF Antibodies and Glucocorticoids

Also Published As

Publication number Publication date
JP2015523572A (ja) 2015-08-13
CO7240371A2 (es) 2015-04-17
EP2872897A1 (en) 2015-05-20
CN105452867A (zh) 2016-03-30
CA2878494A1 (en) 2014-01-16
IL236584A0 (en) 2015-02-26
ZA201500138B (en) 2016-01-27
WO2014009355A1 (en) 2014-01-16
NZ628459A (en) 2016-06-24
EP2872897B1 (en) 2017-10-18
US11402388B2 (en) 2022-08-02
RU2015104160A (ru) 2016-08-27
US20150160235A1 (en) 2015-06-11
KR20150029017A (ko) 2015-03-17
HK1209839A1 (en) 2016-04-08

Similar Documents

Publication Publication Date Title
NO2026005I1 (no) Dorocubicel
FIC20230009I1 (fi) Relatlimabi
NO2022024I1 (no) Roxadustat
EP2763896A4 (en) UNMANUFACTURED AIRCRAFT WITH SEVERAL ROTORS
DK2859055T3 (da) Polymercoatings
HRP20171005T1 (hr) Spojevi imidazopirolidinona
DK2825087T3 (da) Otoscanner
EP2809145A4 (en) CHLOROPLAST TRANSIT PEPTIDES
DK2839013T3 (da) Ikke-disruptiv-gen-targetering
EP2814472A4 (en) DITHIOAMINE REDUCING AGENTS
EP2824794A4 (en) Charging cable
EP2847405A4 (en) DOOR CLOSURE SYSTEM
EP2805877A4 (en) UNDER HOOD
DK2873977T3 (da) Dobbeltdækker-rørdispenser
DE112012006109A5 (de) Okklusionsschienenanordnung
DK2854722T3 (da) Stomipose
CO6990736A2 (es) Pirrolidina-2-carboxamidas sustituídas
EP2831482A4 (en) Flange gasket
EP2816694A4 (en) FLAT CABLE WINDING DEVICE
DK2825157T3 (da) Aminosyrelipider
EP2809729A4 (en) Siloxane polyether copolymers
DK2804611T3 (da) Chitosanafledte forbindelser
DK2740940T3 (da) Dykpumpe
DE112012006214T8 (de) Wulstringwickler
DK2831122T3 (da) Anthocyanidin-kompleks